Claims for Patent: 7,476,779
✉ Email this page to a colleague
Summary for Patent: 7,476,779
| Title: | Generation of plants with altered oil content |
| Abstract: | The present invention is directed to plants that display an altered oil content phenotype due to altered expression of an ICL nucleic acid. The invention is further directed to methods of generating plants with an altered oil content phenotype. |
| Inventor(s): | Lightner; Jonathan (Des Moines, IA), Coate; Jeremy E. (Ithaca, NY), Clendennen; Stephanie K. (Kingsport, TN), Federspiel; Nancy Anne (Menlo Park, CA), Schuster; Debra K. (Portland, OR) |
| Assignee: | Agrinomics LLC (Portland, OR) |
| Application Number: | 10/508,442 |
| Patent Claims: | 1. A method of producing an altered oil content phenotype in a plant, said method comprising: a) introducing into progenitor cells of the plant a plant transformation vector
comprising a CsVMV promoter and a nucleotide sequence that encodes a sequence that encodes an isocitrate lysase (ICL) polypeptide, b) growing the transformed progenitor cells to produce a transgenic plant, wherein said polynucleotide sequence is
expressed, and c) identifying said transgenic plant with an altered oil content phenotype by measuring the oil content in said transgenic plant and comparing it to that of the oil content measured in a control plant.
2. The method of claim 1 wherein the ICL polypeptide has at least 50% sequence identity to the amino acid sequence presented as SEQ ID NO:2, and wherein the sequence comprises an isocitrate lyase domain. 3. The method of claim 1 wherein the ICL polypeptide has at least 80% sequence identity to the amino acid sequence presented as SEQ ID NO:2. 4. The method of claim 1 wherein the ICL polypeptide has at least 90% sequence identity to the amino acid sequence presented as SEQ ID NO:2. 5. The method of claim 1 wherein the ICL polypeptide has the amino acid sequence presented as SEQ ID NO:2. 6. The method of claim 1 wherein an ICL polypeptide is over-expressed in the transgenic plant, and wherein the altered oil content phenotype is a high oil phenotype. 7. A plant obtained by a method of claim 6, wherein the ICL polypeptide has greater than 95% sequence identity to the amino acid sequence presented as SEQ ID NO:2. 8. The plant of claim 7, which is selected from the group consisting of rapeseed, soy, corn, sunflower, cotton, cocoa, safflower, oil palm, coconut palm, flax, castor and peanut. 9. A plant part obtained from a plant according to claim 7. 10. The plant part of claim 9, which is a seed. 11. A transgenic plant comprising a chimeric DNA construct comprising a CsVMV promoter and a DNA encoding an isocitrate lysase (ICL) polypeptide, wherein the ICL polypeptide has greater than 95% sequence identity to the amino acid sequence presented as SEQ ID NO:2, whereby the transgenic plant has an increased level of ICL relative to a non-transgenic plant and wherein oil from the plant has increased content compared to a plant lacking the chimeric DNA construct. 12. A method of improving the oil content produced from a plant, said method comprising: a) introducing into a plant a chimeric DNA construct comprising a plant specific transcription initiation region, a CsVMV promoter and a DNA encoding an isocitrate lysase (ICL) which, when introduced into cells of said plant increases ICL activity in an amount sufficient to increase the quantity of oil produced by the plant compared to a plant lacking the chimeric DNA construct b) identifying said plant with an increased oil content by measuring the oil content in said plant and comparing it to that of the oil content measured in the plant lacking the chimeric DNA construct, thereby providing a method of improving the oil content produced from a plant. 13. The method according to claim 12, wherein the DNA encoding ICL is from a plant selected from the group consisting of rapeseed, soy, corn, sunflower, cotton, cocoa, safflower, oil palm, flax, castor and peanut. |
Details for Patent 7,476,779
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Aimmune Therapeutics, Inc. | PALFORZIA | peanut (arachis hypogaea) allergen powder-dnfp | Powder | 125696 | January 31, 2020 | ⤷ Start Trial | 2023-03-19 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
